Population
Activated human hepatic stellate cells obtained by outgrowth from explants of normal liver obtained after…
Comparison
Endothelin-1, ETB receptor agonist… vs Untreated control cells or vehicle
Design
Preclinical
Authors
Loading...
Hypothesis-generating for cAMP-elevating agents in hepatic fibrosis; leaves open translation to human chronic liver disease.
ET-1 inhibits the proliferation of activated human hepatic stellate cells via ETB receptors through a prostaglandin/cAMP pathway, suggesting that agents increasing cAMP might help limit HSC proliferation in chronic liver diseases.
Mallat et al. (1996) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: